ML Caramori, M Mauer - Current opinion in nephrology and hypertension, 2003 - journals.lww.com Recent findings: There have been advances in the understanding of diabetic
nephropathy pathology. Clearly, structural changes may be advanced before any
clinical findings are apparent. Not all functional consequences of the ... Cited by 68 - Related articles - BL Direct - All 7 versions
- ►kfshrc.edu.sa [PDF] EP Simpson, YK Henry, JS Henkel, RG Smith, … - Neurology, 2004 - AAN Enterprises Method: Serum and CSF samples from sporadic ALS (sALS) patients were assayed for
4-hydroxy-2,3-nonenal (HNE), a lipid peroxidation product, and monocyte
chemoattractant protein-1 (MCP-1 ), a ß-chemokine, by high-performance ... Cited by 61 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org C Cipolletta, KE Ryan, EV Hanna, ER Trimble - Diabetes, 2005 - Am Diabetes Assoc Blood levels of inflammatory markers associated with endothelial dysfunction and
atherosclerosis are increased in diabetic patients; the highest levels occur in
poorly controlled diabetes. We investigated the activation state of ... Cited by 36 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org GS Werner, E Jandt, A Krack, G Schwarz, O … - Circulation, 2004 - Am Heart Assoc Methods and Results— In 104 patients with a chronic total coronary occlusion
(CTO; >2 weeks' duration), collateral function was assessed invasively during
recanalization by intracoronary Doppler and pressure recordings. A ... Cited by 26 - Related articles - BL Direct - All 8 versions
S Yamagishi, K Fukami, S Ueda, S Okuda - Current Drug Targets, 2007 - ingentaconnect.com Abstract: Diabetic nephropathy is a leading cause of end-stage renal failure,
which could account for disabilities and high mortality rates in patients with
diabetes. Diabetic nephropathy seems to occur as a result of an interaction ... Cited by 24 - Related articles - BL Direct - All 2 versions
B Yang, K Houlberg, A Millward, A Demaine - Cytokine, 2004 - Elsevier Cytokines and chemokines have been implicated in the pathogenesis of Type 1
diabetes mellitus (T1DM) and its microvascular complications. Recently, genetic
variants of monocyte chemotactic protein-1 (MCP-1), CC-chemokine receptor 2 ... Cited by 22 - Related articles - All 3 versions
C Mora, JF Navarro - Current Diabetes Reports, 2006 - Springer Diabetic nephropathy has become the main cause of renal failure, but
unfortunately the intimate mecha- nisms leading to the development and
progression of renal injury are not yet fully known. Activated innate ... Cited by 22 - Related articles - BL Direct - All 2 versions
S Kiyici, E Erturk, F Budak, C Ersoy, E Tuncel … - Archives of medical research, 2006 - Elsevier Monocyte chemoattractant protein (MCP)-1 is suggested to be implicated in the
pathogenesis of diabetic nephropathy by activating and recruiting monocytes to
the glomerulus via regulation of adhesion molecule expressions. The aim of ... Cited by 21 - Related articles - All 14 versions
S Yamagishi, T Matsui, K Nakamura - Current drug targets, 2007 - ingentaconnect.com Abstract: Reducing sugars can react non-enzymatically with amino groups of
protein to form Amadori products. These early glycation products undergo further
complex reaction such as rearrangement, dehydration, and condensation to ... Cited by 20 - Related articles - BL Direct - All 3 versions
EM Stuveling, SJL Bakker, HL Hillege, PE … - Nephrology Dialysis Transplantation, 2005 - ERA-EDTA Prevention of end-stage renal disease (ESRD) by early detection and treatment is
an important tool to stop the growing need for renal replacement therapy. The
last decade has brought forward strong reasons for such an approach. The ... Cited by 16 - Related articles - All 13 versions
